Vitamin B12 Forms Compared: Cyano-, Methyl-, Hydroxo- and Adenosyl-Cobalamin (2026 Absorption Guide)

Vitamin B12 (cobalamin) is a family of four related molecules that all end up doing the same two jobs in human metabolism — transferring methyl groups as a cofactor for methionine synthase, and supporting mitochondrial methylmalonyl-CoA mutase — but they differ substantially in stability, cost, and how marketing presents them. Cyanocobalamin is the cheap, shelf-stable form found in most multivitamins. Methylcobalamin is the methylated bioactive form sold at a premium, often alongside MTHFR claims. Hydroxocobalamin has the longest half-life and is the injectable standard in Europe. Adenosylcobalamin (dibencozide) handles mitochondrial energy reactions. Absorption is the larger story — intrinsic factor, gastric acid, PPIs, metformin, and age-related atrophic gastritis matter far more than which form you swallow.

B12 deficiency causes macrocytic anemia, peripheral neuropathy, glossitis, fatigue, and, if prolonged, irreversible spinal cord damage (subacute combined degeneration). The elderly, vegans, and patients on long-term PPIs or metformin are highest risk.

How B12 Is Absorbed

Dietary B12 is bound to animal protein, released by gastric acid and pepsin, briefly bound to haptocorrin in saliva and stomach, then handed to intrinsic factor (secreted by gastric parietal cells) in the duodenum. The B12–IF complex is absorbed via cubilin receptors in the terminal ileum. This saturable pathway caps absorption at roughly 1.5–2 mcg per dose. A second, passive diffusion pathway absorbs about 1% of any oral dose — the reason high-dose oral B12 (1000–2000 mcg) works even when intrinsic factor is absent, as demonstrated in pernicious anemia trials (Kuzminski et al. 1998 Blood; Vidal-Alaball et al. 2005 Cochrane Review).

Who Loses Absorption

• Atrophic gastritis affects roughly 20–30% of adults over 60 (Allen 2009 American Journal of Clinical Nutrition). Reduced acid impairs B12 release from food.
• Proton pump inhibitors and H2 blockers reduce gastric acid and are associated with B12 deficiency on long-term use (Lam et al. 2013 JAMA).
• Metformin reduces B12 absorption in roughly 10–30% of users after several years (de Jager et al. 2010 BMJ).
• Pernicious anemia (autoimmune destruction of parietal cells) eliminates intrinsic factor.
• Gastric bypass and ileal resection bypass or remove the absorption machinery.

Cyanocobalamin

Synthetic, ultra-stable, cheap. Contains a cyanide group cleaved in the body (toxicologically trivial at normal doses — you get more cyanide from almonds). Decades of evidence support it as effective at correcting deficiency (Carmel 2008 Blood; Stabler 2013 NEJM review). It is the form used in most fortified foods and mass-market multis.

Limitation: smokers and people with rare cobalamin metabolism disorders may convert it less efficiently. For general use, cyanocobalamin at 100–1000 mcg/day is effective.

Methylcobalamin

Already methylated, feeds directly into the methionine synthase reaction without requiring the MTR methyltransferase step. Marketed as the form for MTHFR polymorphism carriers, though this claim deserves nuance. MTHFR polymorphisms (C677T, A1298C) affect folate cycling, not B12 cycling per se. The argument that methylcobalamin bypasses a compromised methylation system is plausible but not supported by trials showing superior clinical outcomes for MTHFR carriers specifically.

Methylcobalamin and cyanocobalamin raise serum B12 and correct deficiency comparably in head-to-head studies. Methylcobalamin may elevate intracellular methylcobalamin faster but clinical endpoints (hemoglobin, methylmalonic acid, homocysteine) normalize similarly.

Hydroxocobalamin

Long half-life (retained in tissues longer than cyano- or methyl-), which is why European protocols for pernicious anemia inject 1 mg hydroxocobalamin every 2–3 months after loading. Also the antidote for cyanide poisoning (smoke inhalation): it binds cyanide to form excretable cyanocobalamin. Oral availability is limited but growing in supplements.

Adenosylcobalamin (Dibencozide, Cobamamide)

The active cofactor for methylmalonyl-CoA mutase, which recycles branched-chain amino acid and odd-chain fatty acid metabolites into the Krebs cycle. Marketed for mitochondrial energy support; clinical trial evidence for supplementation (beyond correcting deficiency) is thin. Some sublingual products combine methyl- and adenosylcobalamin to cover both intracellular pools.

Comparison Table

Form	Bioavailability (oral)	Half-life	Best use	Relative cost	Stability
Cyanocobalamin	~1% passive + saturable IF path	Moderate	General supplementation, food fortification	Very low	Excellent
Methylcobalamin	Comparable to cyano	Moderate	Preferred by some for neuropathy, MTHFR context	Moderate	Fair (light sensitive)
Hydroxocobalamin	High when injected; oral limited	Long	IM injections for pernicious anemia, cyanide antidote	Moderate	Good
Adenosylcobalamin	Comparable to cyano	Moderate	Mitochondrial cofactor (stacked with methyl-)	Moderate-high	Fair

Sublingual vs Oral

Sublingual lozenges are often marketed as superior because they "bypass digestion." The RCT evidence is underwhelming: Sharabi et al. 2003 British Journal of Clinical Pharmacology found sublingual and oral cyanocobalamin similarly effective at raising serum B12. The reason oral high-dose B12 works in deficiency is not sublingual absorption — it is passive ileal diffusion of that 1% regardless of intrinsic factor. Do not pay a premium for sublingual unless you prefer the dosage form.

When Injections Are Needed

• Confirmed pernicious anemia (positive intrinsic factor antibodies)
• Severe deficiency with neurological symptoms (rapid repletion matters)
• Inability to take oral medications reliably
• Some clinicians default to injections post-gastrectomy, though high-dose oral is often effective (Kuzminski et al. 1998)

Typical protocol: 1 mg hydroxocobalamin IM every 2–3 days for 2 weeks, then every 2–3 months lifelong. In the U.S., cyanocobalamin 1 mg IM monthly is more common.

Dosing Recommendations

• Healthy omnivores: 2.4 mcg/day RDA is met easily through diet; no routine supplement needed.
• Vegans: 250–500 mcg/day cyanocobalamin or methylcobalamin, or 2000 mcg twice weekly.
• Adults over 60: 100–500 mcg/day cyanocobalamin given absorption risk; many geriatric guidelines now recommend routine supplementation in this age band.
• On PPIs or metformin long-term: test annually; supplement 500–1000 mcg/day if levels trend low.
• Documented deficiency without pernicious anemia: 1000–2000 mcg/day orally is effective in most cases.

Testing

Serum B12 is the standard first test but misses early deficiency — roughly 20% of people with normal serum B12 have elevated methylmalonic acid (MMA), a more sensitive marker (Stabler 2013). In ambiguous cases, request serum MMA and homocysteine. Intrinsic factor antibody testing confirms pernicious anemia.

The MTHFR and Methyl Forms Debate

Direct-to-consumer genetics has popularized the idea that MTHFR variant carriers need methylated vitamins. The honest state of evidence:

• MTHFR C677T homozygotes have reduced enzyme activity, elevating homocysteine modestly.
• Folate supplementation (5-MTHF or folic acid) normalizes homocysteine in these individuals.
• The specific clinical advantage of methylcobalamin over cyanocobalamin for MTHFR carriers is not established in randomized trials.
• For peripheral neuropathy, some small trials favor methylcobalamin (Zhang et al. 2013), but results are inconsistent.

Bottom line: if methylcobalamin costs little more than cyano-, there is no harm. The premium commonly charged for "methylated B vitamins" exceeds what the evidence supports.

How Nutrola Helps

Nutrola's nutrition tracker follows B12 intake across every meal and supplement in 100+ nutrients, with photo AI and voice logging. Vegans, older adults, and anyone on metformin or PPIs can see whether they are hitting the dose they need over weeks, not guessing from a single label. Nutrola's app starts at EUR 2.50/month with zero ads; Nutrola Daily Essentials (USD 49/month, lab tested, EU certified, 100% natural) includes both methyl- and adenosylcobalamin at research-backed doses. Nutrola is rated 4.9 across 1,340,080 reviews.

This article is informational and not medical advice. Severe B12 deficiency with neurological symptoms is a medical emergency — seek care promptly. Do not substitute oral supplementation for prescribed injections without clinician agreement.

Frequently Asked Questions

Is methylcobalamin really better than cyanocobalamin?

In head-to-head trials, both correct deficiency and normalize methylmalonic acid and homocysteine. Methylcobalamin is preferred by some for neuropathy and MTHFR contexts, but the premium charged often exceeds the evidence-based advantage.

How does B12 get absorbed without intrinsic factor?

Approximately 1% of any oral dose diffuses passively across the ileum. High-dose oral B12 (1000–2000 mcg/day) exploits this pathway and is effective in most pernicious anemia patients (Kuzminski et al. 1998), though injections are still standard in severe or neurological cases.

Why do metformin and PPIs cause deficiency?

Metformin impairs calcium-dependent B12 uptake in the ileum; PPIs reduce gastric acid needed to release B12 from food protein. After 2+ years of use, roughly 10–30% of patients show reduced serum B12. Annual testing and low-dose supplementation prevent symptomatic deficiency.

Do I need B12 shots?

Injections are indicated for confirmed pernicious anemia, severe neurological deficiency, or when oral absorption is completely compromised. For most dietary deficiency and routine supplementation, high-dose oral works.

Can I take too much B12?

B12 toxicity is not established at any oral dose; excess is excreted in urine. Some reports link very high serum B12 to underlying pathology (liver disease, myeloproliferative disorders) rather than supplement-related harm. There is no set Tolerable Upper Intake Level.

Which form is best for vegans?

Either cyanocobalamin or methylcobalamin at 250–500 mcg/day, or 2000 mcg twice weekly. Cyanocobalamin is cheaper, equally effective for correcting deficiency, and more stable. Methylcobalamin is a reasonable alternative for those who prefer it.